CTRI/2016/02/006631
Recruiting
Phase 3
Evaluation of clinical efficacy and safety of the Vamana karma followed by Takradhara and Rasaushadhi rasayana chikitsa in Kitibha (psoriasis)
Central council for Research in Ayurvedic sciences CCRAS0 sites110 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Psoriasis (Kitibha)
- Sponsor
- Central council for Research in Ayurvedic sciences CCRAS
- Enrollment
- 110
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Patients of either sex with age between 18 and 60 years
- •2\.Known cases of psoriasis, without psoriatic arthropathy,
- •Exhibiting psoriatic triad â??
- •I.Bright pink or red lesions with pronounced edges, covered with silvery white scales, the scales can be easily separated from the lesion
- •II.Under the scales there appears a pinkish moist tender skin
- •III.With the scarping of the moist skin there appear tiny blood droplets (Auspitzâ??s sign)
- •3\.Patients suffering from psoriasis with less than 50 % of the body surface involvement
- •4\.Patients having less than 10 years duration of disease
- •5\.Positive histopathological finding (Skin\-biopsy \- optional)
Exclusion Criteria
- •1\.Age below 18 years and above 60 years 2\.Patients with other forms of Psoriasis like Guttate or Pustular or Erythrodermic or inverse.
- •3\.Patients suffering from very severe psoriasis with more than 50% of the body surface involvement
- •4\.Patients having chronic disease i.e. more than 10 years duration
- •5\.Patients who are not ready for IPD admission or Vamana Karma or follow up as specified
- •6\.Patients with Psoriatic arthropathy
- •7\.Patients with poorly controlled Hypertension ( more than 160/100 mmHg)
- •8\.Patients with poorly controlled Diabetes Mellitus having Hb A1C of greater than 7\.5%
- •9\.Patients on medication with corticosteroids, phototherapy, biologics, antidepressants any other drugs that may have an influence on the outcome of the study.
- •10\.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
- •11\.Symptomatic patient with clinical evidence of Heart failure.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.HypertensionMedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-004891-16-LVInstitut de Recherches Internationales Servier968
Recruiting
N/A
Evaluation of the clinical efficacy and safety of fluticasone propionate/ formoterol fumarate combination (FFC) for the treatment of bronchial asthma-with and without use of an inhalation deviceBronchial AsthmaJPRN-UMIN000015602Kinki university Department of respiratory medicine and allergology50
Active, Not Recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.HypertensionMedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-004891-16-CZInstitut de Recherches Internationales Servier968
Active, Not Recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.HypertensionMedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-004891-16-PLInstitut de Recherches Internationales Servier968
Active, Not Recruiting
Phase 1
A comparison of a single-pill combination of perindopril/indapamide/amlodipine/bisoprolol with perindopril,indapamide and amlodipine in patients with essential hypertension whose blood pressure remains high on perindopril, indapamide and amlodipine treatment.HypertensionMedDRA version: 20.0Level: PTClassification code 10020772Term: HypertensionSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2020-004891-16-HUInstitut de Recherches Internationales Servier968